Interleukin-1 -6 and Tumor Necrosis Factor-α Release Is Down-Regulated in Whole Blood from Septic Patients

Acta Haematologica

Volumn 95, Issue 3-4, 1996, Pages 268-273

  Kremer, Jean Pierre ^a   Jarrar, Doraid ^b   Steckholzer, Ursula ^c   Ertel, Wolfgang ^c  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

IL 1; IL 6; Proinflammatory cytokines; Sepsis

Indexed keywords

CYTOKINE; ENDOTOXIN; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

CELLULAR IMMUNITY; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DOWN REGULATION; ENDOTOXEMIA; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; SEPSIS;

CYTOKINES; DOWN-REGULATION; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; KINETICS; LIPOPOLYSACCHARIDES; MONOCYTES; RNA, MESSENGER; SEPSIS; SHOCK, SEPTIC; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029997419     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000203895     Document Type: Article

References (33)

1. Michie HR, Manoguc KR, Spriggs DR, Rev-haug A, O’Dwyer S, Dinarello CA, Cerami A, WolfTSM, Wilmore DW: Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 1988;318:1481 — 1486.
2. Van Zee KJ, DeForge LE, Fischer E, Marano MA, Kenney JS, Remick DG, Lowry SF, Mol-dawer LL: ID8 in septic shock, endotoxemia, and after IL-1 administration. J Immunol 1991;146:3478-3482.
3. Martich DG, Danner RL, Ceska M, Suffredini AF: Detection of interleukin-8 and tumor necrosis factor in normal humans after intravenous endotoxin: The effect of antiinflammatory agents. J Exp Med 1991;173:1021-1024.
4. Tracey KJ, Beutler B, Lowry SF, Merryweather J, Woipc S, Milsark IW, Hariri RJ, Fahey TJ, III, Zentella A, Albert JD, Shires GT, Cerami A: Shock and tissue injury induced by recombinant human cachectin. Science 1986;234:470-474.
5. Okusawa S, Gelfand A, Ikejima T, Connolly RJ, Dinarello CA: Interleukin 1 induces a shock-like state in rabbits: Synergism with tumor necrosis factor and the effect of cyclooxy-genase inhibition. J Clin Invest 1988;81:1162— 1172.
6. Dinarello CA: Interleukin-1 and interleukin-1 antagonism. Blood 1991;77:1627-1652.
7. Beutler B, Milsark IW, Cerami AC: Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985;229:869-871.
8. Silva AT, Bayston KF, Cohen J: Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor-a in experimental gram-negative shock. J Infect Dis 1990,162: 421-427.
9. Ohlsson K, Bjork P, Bergenfeldt M, Hageman R, Thompson RC: Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 1990;348:550-552.
10. Van Deventer SJH, Buller HR, ten Cate JW, Sturck A, Pauw W: Endodoxemia: An early predictor of septicemia in febrile patients. Lancet 1988;i:605—610.
11. Shenep JL, Flynn PM, Barrett FF, Stidham GL, Westenkirchner DF: Serial quantitation of endotoxemia and bacteremia during therapy for gram-negative bacterial sepsis. J Infect Dis 1988;157:565-568.
12. Espevik T, Nisscn-Meycr J: A highly sensitive ccll line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods 1986;95: 99-105.
13. Van Snick J, Cayphas S, Vink A, Uyttenhovc C, Coulie G, Rubira MR. Simpson RJ: Purification and NHi-terminal amino acid sequence of a T-cell derived lymphokine with growth factor activity for B-cell hybridomas. Proc Natl Acad Sci USA 1989;83:9679-9683.
14. Chomczynski P, Sacchi N: Single step method of RNA isolation by acid guanidinium thiocya-nate-phenol-chloroform extraction. Anal Bio-chem 1987;162:156-159.
15. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, Cold Spring Harbor Laboratory, 1989.
16. Kremer JP, Reisbach G, Nerl C, Dormer P: B-cell chronic lymphocytic leukemia cells express and release transforming growth factor-p. Br J Haematol 1992;80:480-487.
17. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ. Mathison JC: CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990;249:1431-1433.
18. Knudsen PJ, Dinarello CA, Strom TB: Prostaglandins posttranscriptionally inhibit monocyte expression of interleukin 1 activity by increasing intracellular cyclic adenosine monophosphate. J Immunol 1986; 137:3189-3194.
19. Schindler R, Clark BD, Dinarello CA: Dissociation between IL-lp mRNA and protein synthesis in human peripheral blood mononuclear cells. J Biol Chem 1990;265:10232-10237.
20. Zuckerman SH, Evans GF, Butler LD: Endotoxin tolerance: Independent regulation of interleukin-1 and tumor necrosis factor expression. Infect Immun 1991;59:2774-2780.
21. Esser R, Rhoades K, McBride WH, Morton DL, Economou JS: IL-4 downregulates IL-1 and TNF gene expression in human monocytes. J Immunol 1989;142:3857-3861.
22. De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE: Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174:1209— 1220.
23. Minty A, Chalon P, Derocq JM, Dumont X, Guillemot JC, Kagad M, Labit C, Leplatois P. Liauzun P, Miloux B, Minty C, Casellas P. Loi-son G, Lupker J, Shire D, Ferrara P, Caput D: Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993;362:248-250.
24. Bogdan C, Paik J, Vodovotz Y, Nathan C: Contrasting mechanisms for suppression of macro-phagc cytokine release by transforming growth factor-P and interleukin-10. J Biol Chem 1992; 267:23301-23308.
25. Grbic JT, Mannick JA, Gough DB, Rodrick ML: The role of prostaglandin E? in immune suppression following injury. Ann Surg 1991; 214:253-263.
26. Ayala A, Knotts JK, Ertel W, Perrin MM, Morrison MH, Chaudry IH: Role of interleukin 6 and transforming growth factor-P in the induction of depressed splenocyte responses following sepsis. Arch Surg 1993;128:89-95.
27. Granowitz EV, Porat R, Mier JW, Orencole SF, Kaplanski G, Lynch EA, Ye K, Vannier E, Wolff SM, Dinarello CA: Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans. J Immunol 1993; 151:1637-1645.
28. Rodrick ML, Moss NM, Grbic JT, Revhaug A, O’Dwyer ST, Michie HR, Gough DB, Dubrav-ec D, Manson JM, Saporoschetz IB, Collins KH, Jordan AL, Wilmore DW, Mannick JA: Effects of in vivo endotoxin infusions on in vitro cellular immune responses in humans. J Clin Immunol 1992;12:440-450.
29. Rock CS, Low ry SF: Tumor necrosis factor-a. J Surg Res 1991;51:434-445.
30. Dinarello CA: The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome. J Infect Dis 1991;163:1177-1184.
31. Sheppard BC, Fraker DL, Norton JA: Prevention and treatment of endotoxin and sepsis lethality with recombinant human tumor necrosis factor. Surgery 1989;106:156-162.
32. Cross AS, Sadoff JC, Kelly N, Bernton E, Gemski P: Pretreatment with recombinant murine tumor necrosis factor a/cachectin and murine interleukin-la protects mice from lethal bacterial infection. J Exp Med 1989; 169:2021 -2027.
33. Czuprynski CJ, Brown JF: Recombinant murine interleukin-1 alpha enhancement of nonspecific antibacterial resistance. Infect Immun 1987;55:2061-2065.